IPP Bureau
IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26
By IPP Bureau - May 21, 2026
Company’s EBITDA grew 29.3 per cent to Rs. 290.4 crore, while PAT rose 36.4 per cent to Rs. 137.7 crore
Takeda Pharma ordered to pay $2.5 billion in Amitiza case
By IPP Bureau - May 21, 2026
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration
By IPP Bureau - May 21, 2026
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
Eris Lifesciences reports Q4 FY26 revenue of Rs. 757 crore; PAT jumps 173%
By IPP Bureau - May 21, 2026
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal
By IPP Bureau - May 21, 2026
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
QIAGEN and NVIDIA partner on AI drug discovery
By IPP Bureau - May 21, 2026
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases
Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115M deal
By IPP Bureau - May 21, 2026
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
India reaffirms commitment to global women and child health agenda at WHA 2026
By IPP Bureau - May 21, 2026
Minister J.P. Nadda holds bilateral meeting with Helen Clark, Board Chair of the Partnership for Maternal, Newborn and Child Health in Geneva
ZenMD launches India-focused clinical AI platform for doctors and hospitals
By IPP Bureau - May 21, 2026
Solutions designed to help clinicians reduce administrative burden, improve diagnostic accuracy, and spend more time with patients
Drug Safety Symposium 2026 to focus on real-world impact of pharmacovigilance
By IPP Bureau - May 21, 2026
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
Pfizer advances next-gen pneumococcal vaccine after strong Phase 2 infant data
By IPP Bureau - May 21, 2026
Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
Bristol Myers Squibb & Anthropic redraw biopharma with Claude-powered enterprise AI
By IPP Bureau - May 21, 2026
BMS is moving beyond conversational AI into what it describes as “agentic” systems
National Genomics Infrastructure becomes first global certified core lab for Epigenica’s EpiFinder platform
By IPP Bureau - May 21, 2026
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
Boston Scientific invests $1.5 billion in MiRus for TAVR expansion
By IPP Bureau - May 20, 2026
Deal includes exclusive option to acquire MiRus’ SIEGEL TAVR system for an additional $3 billion upon milestone achievements
